TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37−0.03 (-2.14%)
Close on Nov 18, 2026Market cap $87.31MP/E –Yield –
TuHURA Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
TuHURA Biosciences's enterprise value was $95.80M on Nov 11, 2026, against $99.81M a year earlier. Over the last 5 years it ranged from -$10.55M to $142.48M, with a median of -$297.25K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $95.80M | +165.5% |
| 2025 | Dec 31, 2025 | $36.09M | – |
| 2024 | Dec 31, 2024 | -$1.35M | – |
| 2023 | Dec 29, 2023 | -$1.26M | -229.7% |
| 2022 | Dec 30, 2022 | $971.74K | – |
| 2021 | Dec 31, 2021 | -$3.93M | – |
| 2020 | Dec 31, 2020 | -$6.17M | – |
| 2019 | Dec 31, 2019 | -$5.40M | – |
| 2018 | Dec 31, 2018 | -$3.69M | -449.9% |
| 2017 | Dec 29, 2017 | $1.06M | – |
| 2016 | Dec 30, 2016 | -$1.73M | -153.0% |
| 2015 | Dec 31, 2015 | $3.27M | +45.7% |
| 2014 | Dec 31, 2014 | $2.24M | +0.5% |
| 2013 | Dec 31, 2013 | $2.23M | – |
See a number that looks wrong?